EXPERIMENTAL USE OF ANTI-CANCER AGENTS IN THE PERITONEAL CAVITY.
D000230:Adenocarcinoma; D000970:Antineoplastic Agents; D002277:Carcinoma; D002279:Carcinoma 256, Walker; D002713:Chlorine; D005260:Female; D006801:Humans; D007274:Injections, Intraperitoneal; D009374:Neoplasms, Experimental; D010529:Peritoneal Cavity; D051381:Rats; D012106:Research; D007507:Therapeutic Irrigation; D014116:Toxicology; D014594:Uterine Neoplasms
D000970:Antineoplastic Agents; D002713:Chlorine
ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CARCINOMA 256, WALKER; CHLORINE; EXPERIMENTAL LAB STUDY; INJECTIONS, INTRAPERITONEAL; IRRIGATION; NEOPLASMS, EXPERIMENTAL; PERITONEAL CAVITY; RATS; TOXICOLOGIC REPORT; UTERINE NEOPLASMS